Enanta Pharmaceuticals logo

Enanta Pharmaceuticals Share Price Today

(NASDAQ: ENTA)

Enanta Pharmaceuticals share price is $7.1 & ₹617.48 as on 6 Mar 2025, 2.30 'hrs' IST

$7.1

-0.14

(-1.93%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Enanta Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Enanta Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Enanta Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Enanta Pharmaceuticals share price movements

  • Today's Low: $7.00
    Today's High: $7.49

    Day's Volatility :6.54%

  • 52 Weeks Low: $4.71
    52 Weeks High: $17.80

    52 Weeks Volatility :73.54%

Enanta Pharmaceuticals (ENTA) Returns

PeriodEnanta Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-9.61%
2.1%
0.0%
6 Months
-38.85%
-4.1%
0.0%
1 Year
-53.77%
2.2%
0.0%
3 Years
-89.28%
11.8%
-11.6%

Enanta Pharmaceuticals (ENTA) Key Statistics

in dollars & INR

Previous Close
$7.24
Open
$7.26
Today's High
$7.49
Today's Low
$7.0
Market Capitalization
$156.4M
Today's Volume
$62.1K
52 Week High
$17.8
52 Week Low
$4.71
Revenue TTM
$66.6M
EBITDA
$-107.8M
Earnings Per Share (EPS)
$-4.95
Profit Margin
-157.57%
Quarterly Earnings Growth YOY
-0.66%
Return On Equity TTM
-69.1%

How to invest in Enanta Pharmaceuticals Stock (ENTA) from India?

It is very easy for Indian residents to invest directly in Enanta Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Enanta Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Enanta Pharmaceuticals or ENTA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Enanta Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Enanta Pharmaceuticals shares which would translate to 0.122 fractional shares of Enanta Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Enanta Pharmaceuticals, in just a few clicks!

Returns in Enanta Pharmaceuticals (ENTA) for Indian investors in Rupees

The Enanta Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Enanta Pharmaceuticals investment value today

Current value as on today

₹50,301

Returns

₹49,699

(-49.7%)

Returns from Enanta Pharmaceuticals Stock

₹54,662 (-54.66%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Enanta Pharmaceuticals (ENTA)

43%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Enanta Pharmaceuticals Stock from India on INDmoney has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Enanta Pharmaceuticals

  • Krensavage Asset Management, LLC

    9.93%

  • Farallon Capital Management, L.L.C.

    9.88%

  • BlackRock Inc

    9.56%

  • Vanguard Group Inc

    9.30%

  • Morgan Stanley - Brokerage Accounts

    5.73%

  • RA Capital Management, LLC

    4.87%

Analyst Recommendation on Enanta Pharmaceuticals

Buy

    64%Buy

    28%Hold

    7%Sell

Based on 14 Wall street analysts offering stock ratings for Enanta Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
4
4
4
Sell
1
1
1

Analyst Forecast on Enanta Pharmaceuticals Stock (ENTA)

What analysts predicted

Upside of 113.28%

Target:

$15.14

Current:

$7.10

Insights on Enanta Pharmaceuticals Stock (Ticker Symbol: ENTA)

  • Price Movement

    In the last 1 month, ENTA stock has moved up by 42.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 14.60M → 16.95M (in $), with an average increase of 13.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -28.82M → -22.29M (in $), with an average increase of 29.3% per quarter
  • ENTA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 114.2%
  • ENTA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 136.9%
  • Price to Sales

    ForENTA every $1 of sales, investors are willing to pay $2.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Enanta Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Enanta Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Enanta Pharmaceuticals (ENTA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Enanta Pharmaceuticals Inc logo
41.41%
-38.85%
-53.77%
-89.28%
-85.86%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Enanta Pharmaceuticals Inc logo
NA
NA
0.0
-4.96
-0.69
-0.18
NA
5.24
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Enanta Pharmaceuticals Inc logo
Buy
$156.4M
-85.86%
NA
-157.57%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Enanta Pharmaceuticals

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
Organization
Enanta Pharmaceuticals
Employees
131
CEO
Dr. Jay R. Luly Ph.D.
Industry
Health Technology

Management People of Enanta Pharmaceuticals

NameTitle
Dr. Jay R. Luly Ph.D.
President, CEO & Director
Mr. Paul J. Mellett Jr.
Chief Financial & Administrative Officer
Dr. Yat Sun Or Ph.D.
Chief Scientific Officer
Mr. Matthew P. Kowalsky J.D.
Chief Legal Officer & Corporate Secretary
Dr. Scott T. Rottinghaus M.D.
Chief Medical Office
Ms. Jennifer Viera
Executive Director of Investor Relations & Corporate Communications
Mr. Nathaniel S. Gardiner J.D.
Consultant
Ms. Tara Lynn Kieffer Ph.D.
Chief Product Strategy Officer
Mr. Brendan Luu
Chief Business Officer

Important FAQs about investing in ENTA Stock from India :

What is Enanta Pharmaceuticals share price today?

Enanta Pharmaceuticals share price today stands at $7.10, Open: $7.26 ; Previous Close: $7.24 ; High: $7.49 ; Low: $7.00 ; 52 Week High: $17.80 ; 52 Week Low: $4.71.

The stock opens at $7.26, after a previous close of $7.24. The stock reached a daily high of $7.49 and a low of $7.00, with a 52-week high of $17.80 and a 52-week low of $4.71.

Can Indians buy Enanta Pharmaceuticals shares?

Yes, Indians can invest in the Enanta Pharmaceuticals (ENTA) from India.

With INDmoney, you can buy Enanta Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Enanta Pharmaceuticals at zero transaction cost.

How can I buy Enanta Pharmaceuticals shares from India?

It is very easy to buy Enanta Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Enanta Pharmaceuticals (ENTA) be purchased?

Yes, you can buy fractional shares of Enanta Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Enanta Pharmaceuticals stocks?

To start investing in Enanta Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Enanta Pharmaceuticals Stock (ENTA)?

Today’s highest price of Enanta Pharmaceuticals (ENTA) is $7.49.

Today’s lowest price of Enanta Pharmaceuticals (ENTA) is $7.00.

What is today's market capitalisation of Enanta Pharmaceuticals?

Today's market capitalisation of Enanta Pharmaceuticals ENTA is 156.4M

What is the 52 Week High and Low Range of Enanta Pharmaceuticals Stock (ENTA)?

  • 52 Week High

    $17.80

  • 52 Week Low

    $4.71

What are the historical returns of Enanta Pharmaceuticals (ENTA)?

  • 1 Month Returns

    41.41%

  • 3 Months Returns

    -38.85%

  • 1 Year Returns

    -53.77%

  • 5 Years Returns

    -85.86%

Who is the Chief Executive Officer (CEO) of Enanta Pharmaceuticals ?

Dr. Jay R. Luly Ph.D. is the current Chief Executive Officer (CEO) of Enanta Pharmaceuticals.